Answer
Pure red cell aplasia reported with Aranesp (darbepoetin alfa) is caused by neutralising anti-erythropoietin antibodies and has predominantly been reported in patients with chronic renal failure treated subcutaneously.
Sources for this answer
- Aranesp solution for injection in pre-filled syringe / Aranesp solution for injection in pre-filled syringe with needle guardAmgen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked